EDGAR Filing Documents for 0001193125-11-214273

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-11-214273

Filing Date

2011-08-08

Accepted

2011-08-08 16:23:12

Documents

Period of Report

2011-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	481915
2	SECTION 302 CEO CERTIFICATION	dex311.htm	EX-31.1	9586
3	SECTION 302 CFO CERTIFICATION	dex312.htm	EX-31.2	9740
4	SECTION 906 CEO CERTIFICATION	dex321.htm	EX-32.1	4528
5	SECTION 906 CFO CERTIFICATION	dex322.htm	EX-32.2	3783
	Complete submission text file	0001193125-11-214273.txt		1523620

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	achn-20110630.xml	EX-101.INS	125480
7	XBRL TAXONOMY EXTENSION SCHEMA	achn-20110630.xsd	EX-101.SCH	10998
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	achn-20110630_cal.xml	EX-101.CAL	27229
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	achn-20110630_lab.xml	EX-101.LAB	100153
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	achn-20110630_pre.xml	EX-101.PRE	63335

Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511

Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000

ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)